Submissions from 2016
Novel Aspiration Thrombectomy for Intervention of Peripheral and Visceral Arterial Occlusions: The PRISM Trial Results, James Benenati
Off-label Use of Arterial Chronic Total Occlusion Devices to Cross Venous CTOs, Constantino Pena
Off-label Use of Flow Diverters, Guilherme Dabus
Off-Label Use of Flow Diverters, Guilherme Dabus
Opening Mesenteric Occlusions: When and How, James Benenati
Optimal Approach to Persistent Type II Endoleaks with Sac Expansion, Barry Katzen
Optimal Techniques: Tips and Tricks of WATCHMAN Device Implant, Ramon Quesada
Outcome Prediction After Intra-arterial Therapy for Acute Ischemic Stroke, Guilherme Dabus
Overview on New-Generation EVAR Devices: What Will Be the Winner?, Barry Katzen
Pelvic Congestion Syndrome: Who Should We Treat and Will Hemorrhoids Be the Next Interventional Target?, Constantino Pena
Peripheral Artery Disease: Strategies for Intervention of Chronic Occlusive Ischemia, Constantino Pena
Personalized Dosimetry for Y90 Radioembolization: Just the Right Amount, Ripal Gandhi
PFO Closure for Cryptogenic Stroke: Evolving Evidence and Technology, Ramon Quesada
Podcast: Predictors of poor outcome despite recanalization: a multiple regression analysis of the NASA registry, Italo Linfante
Post-Procedural Care of the Venous Patient: Role of Compression Therapy, Antiplatelet Therapy and Anticoagulation, James Benenati
Preprocedural Evaluation for Carotid Intervention, Barry Katzen
Radial Access, Ripal Gandhi
Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR, Barry Katzen
Robotics: State of the Art in Endovascular Therapy, Ripal Gandhi
Should We Embolize Middle Cerebral Artery Aneurysms?, Guilherme Dabus
Small AAA Should Be Treated by EVAR (Cons), Barry Katzen
Solitaire™ Platinum: First Clinical Experience from the U.S., Italo Linfante
Standard EVAR, James Benenati
State-of-the-Art Lecture: Limitations with Current EVAR Technology and What Lies Ahead, Barry Katzen